Digma Medical is a clinical stage medical device company developing a novel endoscopic treatment for metabolic disease designed to complement standard medical management.

The Digma System ablates the duodenum to interrupt metabolic signaling pathways, reducing insulin resistance and improving glycemic control.

Our mission is to empower patients and physicians with safe, simple and effective new therapies for metabolic disease that dramatically improve quality of life and long-term health outcomes.